Cargando…
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and persistent human papilloma virus (HPV)-induced wart...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537207/ https://www.ncbi.nlm.nih.gov/pubmed/35527320 http://dx.doi.org/10.1007/s10875-022-01279-5 |
_version_ | 1784803148480643072 |
---|---|
author | Melsen, Janine E. van Ostaijen-ten Dam, Monique M. van den Akker, Erik B. Welters, Marij J. P. Heezen, Kim C. Pico-Knijnenburg, Ingrid Kolijn, P. Martijn Bredius, Robbert G. M. van Doorn, Remco Langerak, Anton W. Schilham, Marco W. Lankester, Arjan C. |
author_facet | Melsen, Janine E. van Ostaijen-ten Dam, Monique M. van den Akker, Erik B. Welters, Marij J. P. Heezen, Kim C. Pico-Knijnenburg, Ingrid Kolijn, P. Martijn Bredius, Robbert G. M. van Doorn, Remco Langerak, Anton W. Schilham, Marco W. Lankester, Arjan C. |
author_sort | Melsen, Janine E. |
collection | PubMed |
description | The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and persistent human papilloma virus (HPV)-induced warts, the patient received a peripheral stem cell boost at the age of 37 years. NK and T cells were assessed before and up to 14 years after the boost by flow cytometry. The boost induced renewed reconstitution of functional NK cells that were 14 years later enriched for CD56(dim)CD27(+) NK cells. T-cell phenotype and T-cell receptor (TCR) repertoire were simultaneously analyzed by including TCR Vβ antibodies in the cytometry panel. Naive T-cell numbers with a diverse TCR Vβ repertoire were increased by the boost. Before and after the boost, clonal expansions with a homogeneous TIGIT and PD-1 phenotype were identified in the CD27(−) and/or CD28(−) memory population in the patient, but not in the donor. TRB sequencing was applied on sorted T-cell subsets from blood and on T cells from skin biopsies. Abundant circulating CD8 memory clonotypes with a chronic virus-associated CD57(+)KLRG1(+)CX3CR1(+) phenotype were also present in warts, but not in healthy skin of the patient, suggesting a link with HPV. In conclusion, we demonstrate in this IL2RG-deficient patient functional NK cells, a diverse and lasting naive T-cell compartment, supported by a stem cell boost, and an oligoclonal memory compartment half a century after HSCT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01279-5. |
format | Online Article Text |
id | pubmed-9537207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95372072022-10-08 T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation Melsen, Janine E. van Ostaijen-ten Dam, Monique M. van den Akker, Erik B. Welters, Marij J. P. Heezen, Kim C. Pico-Knijnenburg, Ingrid Kolijn, P. Martijn Bredius, Robbert G. M. van Doorn, Remco Langerak, Anton W. Schilham, Marco W. Lankester, Arjan C. J Clin Immunol Original Article The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and persistent human papilloma virus (HPV)-induced warts, the patient received a peripheral stem cell boost at the age of 37 years. NK and T cells were assessed before and up to 14 years after the boost by flow cytometry. The boost induced renewed reconstitution of functional NK cells that were 14 years later enriched for CD56(dim)CD27(+) NK cells. T-cell phenotype and T-cell receptor (TCR) repertoire were simultaneously analyzed by including TCR Vβ antibodies in the cytometry panel. Naive T-cell numbers with a diverse TCR Vβ repertoire were increased by the boost. Before and after the boost, clonal expansions with a homogeneous TIGIT and PD-1 phenotype were identified in the CD27(−) and/or CD28(−) memory population in the patient, but not in the donor. TRB sequencing was applied on sorted T-cell subsets from blood and on T cells from skin biopsies. Abundant circulating CD8 memory clonotypes with a chronic virus-associated CD57(+)KLRG1(+)CX3CR1(+) phenotype were also present in warts, but not in healthy skin of the patient, suggesting a link with HPV. In conclusion, we demonstrate in this IL2RG-deficient patient functional NK cells, a diverse and lasting naive T-cell compartment, supported by a stem cell boost, and an oligoclonal memory compartment half a century after HSCT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01279-5. Springer US 2022-05-09 2022 /pmc/articles/PMC9537207/ /pubmed/35527320 http://dx.doi.org/10.1007/s10875-022-01279-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Melsen, Janine E. van Ostaijen-ten Dam, Monique M. van den Akker, Erik B. Welters, Marij J. P. Heezen, Kim C. Pico-Knijnenburg, Ingrid Kolijn, P. Martijn Bredius, Robbert G. M. van Doorn, Remco Langerak, Anton W. Schilham, Marco W. Lankester, Arjan C. T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation |
title | T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation |
title_full | T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation |
title_fullStr | T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation |
title_full_unstemmed | T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation |
title_short | T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation |
title_sort | t and nk cells in il2rg-deficient patient 50 years after hematopoietic stem cell transplantation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537207/ https://www.ncbi.nlm.nih.gov/pubmed/35527320 http://dx.doi.org/10.1007/s10875-022-01279-5 |
work_keys_str_mv | AT melsenjaninee tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT vanostaijentendammoniquem tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT vandenakkererikb tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT weltersmarijjp tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT heezenkimc tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT picoknijnenburgingrid tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT kolijnpmartijn tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT brediusrobbertgm tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT vandoornremco tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT langerakantonw tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT schilhammarcow tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation AT lankesterarjanc tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation |